Optimizing Efficiency in Clinical Microbiology Labs: Steps to Avoid Unnecessary Tests Through Diagnostic and Antimicrobial Stewardship

Originally aired May 24, 2022


60-Minute Webinar Sponsored By

Magnolia Medical Technologies Webinar

Why you should attend

During this webinar, our expert panel will: 

  • Review the current state of hospital quality outcomes three years into the pandemic
  • Help participants understand the current and predicted future state of antimicrobial resistance (AMR)
  • Discuss the link between diagnostic errors and AMR and antibiotic-related infections, with a focus on the impact of blood culture contamination
  • Detail evidence-based practices that mitigate false-positive cultures and contribute to hospital diagnostic stewardship, AMS, and quality goals
  • Share how a major medical center achieved a significant decrease in vancomycin days of therapy (DOT)

About this webinar

In September 2021, a CDC report found that hospital-acquired infections had increased significantly in 2020 after years of steady decline. Standard infection prevention practices have been impacted by staffing shortages and chaotic work environments, which has subsequently created an environment that is susceptible for diagnostic errors. These factors indicate a troubling trend working against antimicrobial and diagnostic stewardship efforts.

As a result, hospital and healthcare system leaders are re-focusing their attention on patient safety and quality outcomes—and trying to solve the problems of blood culture contamination, which can lead to a misdiagnosis of sepsis. With those goals in mind, a new webinar from Dark Daily will focus on practical and effective solutions designed to reduce the risk of antibiotic-related infections, antimicrobial resistance, and false-positive blood cultures.

Featuring a case study and live Q&A, the webinar will review the quality improvement (QI) project of a 425-bed academic medical center. We will examine the impact of a 90% reduction in blood culture contamination rates and the direct effect on antimicrobial stewardship efforts which resulted in a 31% reduction in vancomycin days of therapy (DOT).


Expert Panel

Barb DeBaun, RN, MSN, CIC

Improvement Advisor

Cynosure Health

Barbara DeBaun has over 40 years of experience in the field of infection prevention and quality improvement. She is currently an Improvement Advisor with Cynosure Health. Previously, she was the Director of Patient Safety and Infection Control at California Pacific Medical Center in San Francisco. Barbara is a certified Infection Control Practitioner and holds a bachelor’s degree in nursing from Pace University in New York and a Master of Science Degree in Nursing from San Francisco State University. Barbara is certified in Infection Control and is adjunct faculty at Dominican University in California.

Lindsey Nielsen, PhD, D(AMBB)

Laboratory Director

Lindsey Nielsen, PhD, D(ABMM) is a Diplomat of the American Board of Medical Microbiology and CLIA-laboratory director at a newly established molecular infectious disease laboratory. Previously a founding Director of Clinical Services of an independent community hospital overseeing laboratory, pharmacy, radiology, rehabilitation therapy, respiratory therapy, and nutrition departments, Dr. Nielsen currently serves as a US Army officer in the Reserves after being Active Duty as a Clinical Microbiologist at Walter Reed and Brooke Army Medical Center. Dr. Nielsen also owns a laboratory consultation business where she has directed multiple clinical laboratories and served as technical supervisor and consultant.

Who should attend?

  • Lab manager/director/VP
  • ED nurse/manager/director/VP
  • Phlebotomist and phlebotomy supervisor
  • Quality improvement leader
  • Infection preventionist
  • Clinical pharmacist
  • Antibiotic stewardship committee
  • Sepsis protocol team
  • Value analysis team member

Hosted By

dark daily logo-no tags-FIT-white